These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 15486522)

  • 21. Aripiprazole: new drug. Just another neuroleptic.
    Prescrire Int; 2005 Oct; 14(79):163-7. PubMed ID: 16285069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case report of neuroleptic malignant syndrome without fever in a patient given aripiprazole.
    Rodriguez OP; Dowell MS
    J Okla State Med Assoc; 2006; 99(7):435-8. PubMed ID: 17017330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases.
    Croarkin PE; Emslie GJ; Mayes TL
    J Clin Psychiatry; 2008 Jul; 69(7):1157-65. PubMed ID: 18572981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aripiprazole and atypical neuroleptic malignant syndrome.
    Spalding S; Alessi NE; Radwan K
    J Am Acad Child Adolesc Psychiatry; 2004 Dec; 43(12):1457-8. PubMed ID: 15564813
    [No Abstract]   [Full Text] [Related]  

  • 25. Pathological gambling and the treatment of psychosis with aripiprazole: case reports.
    Smith N; Kitchenham N; Bowden-Jones H
    Br J Psychiatry; 2011 Aug; 199(2):158-9. PubMed ID: 21804151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and tolerability of once monthly aripiprazole treatment initiation in adults with schizophrenia stabilized on selected atypical oral antipsychotics other than aripiprazole.
    Potkin SG; Raoufinia A; Mallikaarjun S; Bricmont P; Peters-Strickland T; Kasper W; Baker RA; Eramo A; Sanchez R; McQuade R
    Curr Med Res Opin; 2013 Oct; 29(10):1241-51. PubMed ID: 23822566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroleptic malignant syndrome with the addition of aripiprazole to clozapine.
    Dassa D; Drai-Moog D; Samuelian JC
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):427-8. PubMed ID: 20080143
    [No Abstract]   [Full Text] [Related]  

  • 28. A case of aripiprazole and tardive dyskinesia.
    Abbasian C; Power P
    J Psychopharmacol; 2009 Mar; 23(2):214-5. PubMed ID: 18515468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroleptic malignant syndrome from aripiprazole in an agitated pediatric patient.
    Palakurthi HB; Parvin MM; Kaplan S
    Clin Neuropharmacol; 2007; 30(1):47-51. PubMed ID: 17272970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.
    Ozen ME; Yumru M; Savas HA; Cansel N; Herken H
    World J Biol Psychiatry; 2007; 8(1):42-4. PubMed ID: 17366349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cochrane for clinicians. Aripiprazole vs. other atypical antipsychotics for schizophrenia.
    Guirguis-Blake J
    Am Fam Physician; 2010 Jun; 81(11):1335-6. PubMed ID: 20521753
    [No Abstract]   [Full Text] [Related]  

  • 32. Extreme elevation of creatinine phosphokinase levels in neuroleptic malignant syndrome associated with atypical antipsychotics.
    Ladds B; Thomas P; Mejia C; Hauser D
    Am J Psychiatry; 2009 Jan; 166(1):114-5. PubMed ID: 19122020
    [No Abstract]   [Full Text] [Related]  

  • 33. Aripiprazole: new indication. Treatment and prevention of manic episodes: just another neuroleptic.
    Prescrire Int; 2009 Jun; 18(101):117. PubMed ID: 19637429
    [No Abstract]   [Full Text] [Related]  

  • 34. Aripiprazole-induced rabbit syndrome in a drug-naive schizophrenic patient.
    Gonidakis F; Ploubidis D; Papadimitriou G
    Schizophr Res; 2008 Aug; 103(1-3):341-2. PubMed ID: 18262773
    [No Abstract]   [Full Text] [Related]  

  • 35. Management of acute agitation in patients with bipolar disorder: efficacy and safety of intramuscular aripiprazole.
    Zimbroff DL; Marcus RN; Manos G; Stock E; McQuade RD; Auby P; Oren DA
    J Clin Psychopharmacol; 2007 Apr; 27(2):171-6. PubMed ID: 17414241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improvement of tardive dyskinesia and dystonia associated with aripiprazole following a switch to quetiapine: case report and review of the literature.
    Ono S; Suzuki Y; Shindo M; Endo T; Fukui N; Sugai T; Someya T
    J Clin Pharm Ther; 2012 Jun; 37(3):370-2. PubMed ID: 22023382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial.
    Barbui C; Accordini S; Nosè M; Stroup S; Purgato M; Girlanda F; Esposito E; Veronese A; Tansella M; Cipriani A;
    J Clin Psychopharmacol; 2011 Jun; 31(3):266-73. PubMed ID: 21508849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroleptic malignant syndrome with aripiprazole in Huntington's disease.
    Gahr M; Orth M; Abler B
    Mov Disord; 2010 Oct; 25(14):2475-6. PubMed ID: 20669301
    [No Abstract]   [Full Text] [Related]  

  • 39. Neuroleptic rechallenge with aripiprazole in a patient with previously documented neuroleptic malignant syndrome.
    Trutia A; Bledowski J; Pandurangi A; Kahn DA
    J Psychiatr Pract; 2008 Nov; 14(6):398-402. PubMed ID: 19057242
    [No Abstract]   [Full Text] [Related]  

  • 40. A systematic review of reported cases involving psychotic symptoms worsened by aripiprazole in schizophrenia or schizoaffective disorder.
    Takeuchi H; Remington G
    Psychopharmacology (Berl); 2013 Jul; 228(2):175-85. PubMed ID: 23736279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.